Distinct Effects on Diversifying Selection by Two Mechanisms of Immunity against Streptococcus pneumoniae

PLoS Pathogens

Volumn 8, Issue 11, 2012, Pages

  Li, Yuan ^a   Gierahn, Todd ^b   Thompson, Claudette M ^a   Trzciński, Krzysztof ^c   Ford, Christopher B ^a   Croucher, Nicholas ^a   Gouveia, Paulo ^b   Flechtner, Jessica B ^b   Malley, Richard ^d   Lipsitch, Marc ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b Cambridge Discovery Park   (United States)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; EPITOPE; INTERLEUKIN 17; OVALBUMIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIGEN RECOGNITION; ANTIGENIC VARIATION; ANTIGENICITY; ARTICLE; BACTERIAL COLONIZATION; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DIVERSIFYING SELECTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC SCREENING; HUMAN; IMMUNE RESPONSE; MICROBIAL DIVERSITY; MOUSE; NONHUMAN; NORMAL HUMAN; POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; STREPTOCOCCUS PNEUMONIAE; TH17 CELL;

ANIMALS; ANTIGENS, BACTERIAL; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITOPES; FEMALE; HUMANS; IMMUNE EVASION; IMMUNITY, CELLULAR; MICE; MICE, INBRED BALB C; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; STREPTOCOCCUS PNEUMONIAE; TH17 CELLS;

STREPTOCOCCUS PNEUMONIAE;

EID: 84870803433     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1002989     Document Type: Article

References (50)

1. Lipsitch M, O'Hagan JJ, (2007) Patterns of antigenic diversity and the mechanisms that maintain them. J R Soc Interface 4: 787-802.
2. Ma W, Guttman DS, (2008) Evolution of prokaryotic and eukaryotic virulence effectors. Curr Opin Plant Biol 11: 412-419.
3. Weedall GD, Conway DJ, (2010) Detecting signatures of balancing selection to identify targets of anti-parasite immunity. Trends Parasitol 26: 363-369.
4. Frost SD, Wrin T, Smith DM, Kosakovsky Pond SL, Liu Y, et al. (2005) Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. Proc Natl Acad Sci U S A 102: 18514-18519.
5. Liu Y, McNevin J, Cao J, Zhao H, Genowati I, et al. (2006) Selection on the human immunodeficiency virus type 1 proteome following primary infection. J Virol 80: 9519-9529.
6. Goulder PJ, Brander C, Tang Y, Tremblay C, Colbert RA, et al. (2001) Evolution and transmission of stable CTL escape mutations in HIV infection. Nature 412: 334-338.
7. Plotkin JB, Dushoff J, Levin SA, (2002) Hemagglutinin sequence clusters and the antigenic evolution of influenza A virus. Proc Natl Acad Sci U S A 99: 6263-6268.
8. Simonsen L, Viboud C, Grenfell BT, Dushoff J, Jennings L, et al. (2007) The genesis and spread of reassortment human influenza A/H3N2 viruses conferring adamantane resistance. Mol Biol Evol 24: 1811-1820.
9. Polley SD, Conway DJ, (2001) Strong diversifying selection on domains of the Plasmodium falciparum apical membrane antigen 1 gene. Genetics 158: 1505-1512.
10. Baum J, Thomas AW, Conway DJ, (2003) Evidence for diversifying selection on erythrocyte-binding antigens of Plasmodium falciparum and P. vivax. Genetics 163: 1327-1336.
11. Birrer MJ, Udem S, Nathenson S, Bloom BR, (1981) Antigenic variants of measles virus. Nature 293: 67-69.
12. Comas I, Chakravartti J, Small PM, Galagan J, Niemann S, et al. (2010) Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42: 498-503.
13. Cobey S, Lipsitch M, (2012) Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science 335: 1376-1380.
14. Weinberger DM, Dagan R, Givon-Lavi N, Regev-Yochay G, Malley R, et al. (2008) Epidemiologic evidence for serotype-specific acquired immunity to pneumococcal carriage. J Infect Dis 197: 1511-1518.
15. Malley R, (2010) Antibody and cell-mediated immunity to Streptococcus pneumoniae: implications for vaccine development. J Mol Med (Berl) 88: 135-142.
16. Goldblatt D, Hussain M, Andrews N, Ashton L, Virta C, et al. (2005) Antibody responses to nasopharyngeal carriage of Streptococcus pneumoniae in adults: a longitudinal household study. J Infect Dis 192: 387-393.
17. Malley R, Lipsitch M, Bogaert D, Thompson CM, Hermans P, et al. (2007) Serum antipneumococcal antibodies and pneumococcal colonization in adults with chronic obstructive pulmonary disease. J Infect Dis 196: 928-935.
18. Trzcinski K, Thompson C, Malley R, Lipsitch M, (2005) Antibodies to conserved pneumococcal antigens correlate with, but are not required for, protection against pneumococcal colonization induced by prior exposure in a mouse model. Infect Immun 73: 7043-7046.
19. Rapola S, Jantti V, Haikala R, Syrjanen R, Carlone GM, et al. (2000) Natural development of antibodies to pneumococcal surface protein A, pneumococcal surface adhesin A, and pneumolysin in relation to pneumococcal carriage and acute otitis media. J Infect Dis 182: 1146-1152.
20. Simell B, Korkeila M, Pursiainen H, Kilpi TM, Kayhty H, (2001) Pneumococcal carriage and otitis media induce salivary antibodies to pneumococcal surface adhesin a, pneumolysin, and pneumococcal surface protein a in children. J Infect Dis 183: 887-896.
21. Briles DE, Hollingshead SK, King J, Swift A, Braun PA, et al. (2000) Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA. J Infect Dis 182: 1694-1701.
22. Cui Y, Zhang X, Gong Y, Niu S, Yin N, et al. (2011) Immunization with DnaJ (hsp40) could elicit protection against nasopharyngeal colonization and invasive infection caused by different strains of Streptococcus pneumoniae. Vaccine 29: 1736-1744.
23. Trzcinski K, Thompson CM, Srivastava A, Basset A, Malley R, et al. (2008) Protection against nasopharyngeal colonization by Streptococcus pneumoniae is mediated by antigen-specific CD4+ T cells. Infect Immun 76: 2678-2684.
24. Giefing C, Meinke AL, Hanner M, Henics T, Bui MD, et al. (2008) Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodies. J Exp Med 205: 117-131.
25. Malley R, Trzcinski K, Srivastava A, Thompson CM, Anderson PW, et al. (2005) CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization. Proc Natl Acad Sci U S A 102: 4848-4853.
26. Basset A, Thompson CM, Hollingshead SK, Briles DE, Ades EW, et al. (2007) Antibody-independent, CD4+ T-cell-dependent protection against pneumococcal colonization elicited by intranasal immunization with purified pneumococcal proteins. Infect Immun 75: 5460-5464.
27. Lu YJ, Forte S, Thompson CM, Anderson PW, Malley R, (2009) Protection against Pneumococcal colonization and fatal pneumonia by a trivalent conjugate of a fusion protein with the cell wall polysaccharide. Infect Immun 77: 2076-2083.
28. Lu YJ, Skovsted IC, Thompson CM, Anderson PW, Malley R, (2009) Mechanisms in the serotype-independent pneumococcal immunity induced in mice by intranasal vaccination with the cell wall polysaccharide. Microb Pathog 47: 177-182.
29. Harfouche C, Filippini S, Gianfaldoni C, Ruggiero P, Moschioni M, et al. (2012) RrgB321, a fusion protein of the three variants of the pneumococcal pilus backbone RrgB, is protective in vivo and elicits opsonic antibodies. Infect Immun 80: 451-460.
30. Malley R, Srivastava A, Lipsitch M, Thompson CM, Watkins C, et al. (2006) Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide. Infect Immun 74: 2187-2195.
31. Lu YJ, Gross J, Bogaert D, Finn A, Bagrade L, et al. (2008) Interleukin-17A mediates acquired immunity to pneumococcal colonization. PLoS Pathog 4: e1000159.
32. Zhang Z, Clarke TB, Weiser JN, (2009) Cellular effectors mediating Th17-dependent clearance of pneumococcal colonization in mice. J Clin Invest 119: 1899-1909.
33. Bogaert D, Engelen MN, Timmers-Reker AJ, Elzenaar KP, Peerbooms PG, et al. (2001) Pneumococcal carriage in children in The Netherlands: a molecular epidemiological study. J Clin Microbiol 39: 3316-3320.
34. Lechner M, Findeiss S, Steiner L, Marz M, Stadler PF, et al. (2011) Proteinortho: detection of (co-)orthologs in large-scale analysis. BMC Bioinformatics 12: 124.
35. Loytynoja A, Goldman N, (2005) An algorithm for progressive multiple alignment of sequences with insertions. Proc Natl Acad Sci U S A 102: 10557-10562.
36. Yang Z, (2007) PAML 4: phylogenetic analysis by maximum likelihood. Mol Biol Evol 24: 1586-1591.
37. Yang Z, Wong WS, Nielsen R, (2005) Bayes empirical bayes inference of amino acid sites under positive selection. Mol Biol Evol 22: 1107-1118.
38. Zeger SL, Liang KY, (1986) Longitudinal data analysis for discrete and continuous outcomes. Biometrics 42: 121-130.
39. Thompson JD, Gibson TJ, Higgins DG, (2002) Multiple sequence alignment using ClustalW and ClustalX. Curr Protoc Bioinformatics Chapter 2: Unit 2 3.
40. Wilson DJ, McVean G, (2006) Estimating diversifying selection and functional constraint in the presence of recombination. Genetics 172: 1411-1425.
41. Wucherpfennig KW, (2004) T cell receptor crossreactivity as a general property of T cell recognition. Mol Immunol 40: 1009-1017.
42. Weber SE, Tian H, Pirofski LA, (2011) CD8+ cells enhance resistance to pulmonary serotype 3 Streptococcus pneumoniae infection in mice. J Immunol 186: 432-442.
43. Sun K, Salmon SL, Lotz SA, Metzger DW, (2007) Interleukin-12 promotes gamma interferon-dependent neutrophil recruitment in the lung and improves protection against respiratory Streptococcus pneumoniae infection. Infect Immun 75: 1196-1202.
44. Scherf A, Lopez-Rubio JJ, Riviere L, (2008) Antigenic variation in Plasmodium falciparum. Annu Rev Microbiol 62: 445-470.
45. Maiden MC, Ibarz-Pavon AB, Urwin R, Gray SJ, Andrews NJ, et al. (2008) Impact of meningococcal serogroup C conjugate vaccines on carriage and herd immunity. J Infect Dis 197: 737-743.
46. Lu YJ, Zhang F, Sayeed S, Thompson CM, Szu S, et al. (2012) A bivalent vaccine to protect against Streptococcus pneumoniae and Salmonella typhi. Vaccine 30: 3405-3412.
47. Sung CK, Li H, Claverys JP, Morrison DA, (2001) An rpsL cassette, janus, for gene replacement through negative selection in Streptococcus pneumoniae. Appl Environ Microbiol 67: 5190-5196.
48. Streeck H, Cohen KW, Jolin JS, Brockman MA, Meier A, et al. (2008) Rapid ex vivo isolation and long-term culture of human Th17 cells. J Immunol Methods 333: 115-125.
49. Moffitt KL, Gierahn TM, Lu YJ, Gouveia P, Alderson M, et al. (2011) T(H)17-based vaccine design for prevention of Streptococcus pneumoniae colonization. Cell Host Microbe 9: 158-165.
50. Delcher AL, Bratke KA, Powers EC, Salzberg SL, (2007) Identifying bacterial genes and endosymbiont DNA with Glimmer. Bioinformatics 23: 673-679.